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Abstract		
INTRODUCTION:		
	The	many	radiographic	damage	scoring	methods	in	rheumatoid	arthritis	(RA)	patients	
such	as	the	Sharp	van	der	Heijde	(SHS)	method	are	difficult	to	implement	in	a	clinical	
setting.	The	Simple	Erosion	and	Narrowing	Score	(SENS)	method	as	well	as	the	Scott	
modification	of	the	Larsen	scoring	method	are	both	easier	to	perform	and	reliable	in	early	
RA.		
OBJECTIVES:	
To	evaluate	the	level	of	agreement	between	two	scoring	methods,	the	modified	Larsen	
and	SENS,	and	to	correlate	these	scoring	systems	between	radiographic	damage,	disease	
activity	and	disability	in	early	disease	modifying	antirheumatic	drug	(DMARD)	naïve	RA	
patients	
METHOD:		
Baseline	digital	radiographs	of	hands	and	feet	of	RA	patients	attending	the	Arthritis	clinic	
of	the	Chris	Hani	Baragwanath	Academic	Hospital	were	independently	scored	by	2	
radiologists	using	the	modified	Larsen	and	SENS	methods.	All	patients	were	DMARD	naive	
with	a	symptom	duration	of	≤	2years.	Baseline	clinical	data,	disease	activity	as	calculated	
by	the	simplified	and	the	clinical	disease	activity	index	and	physical	disability	as	measured	
by	the	health	assessment	questionnaire	was	obtained	from	the	METEOR	database.		The	
Spearman	covariant	assessed	the	correlation	between	the	two	scoring	systems,	and	
between	radiological	scores	and	disease	activity	and	physical	function.	
RESULTS:		
There	is	strong	correlation	(r=	0.892;	p-value	0.00)	between	the	SENS	and	the	modified	
Larsen	scoring	methods	in	patients	with	early	RA.	There	is	no	significant	correlation	
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between	the	modified	Larsen	score	and	the	SENS	and	disease	activity	measures,	(CDAI	(p-
value	0.479)	and	SDAI	(p-value	0.746))	and	(CDAI	p-value	0.77;	SDAI	p-value	0.86))	
respectively.	There	is	no	correlation	between	the	modified	Larsen	score	and	the	SENS	
with	the	HAQ,	(r	=	-0.168;	p-value	0.104)	and	(r=	-0.101;	p-value	0.332)	respectively.	
CONCLUSIONS:	
Both	the	SENS	and	the	modified	Larsen	scoring	method	are	simple	to	perform	and	have	a	
high	level	of	agreement	in	early	RA.	There	is	no	correlation	between	either	scoring	
methods	with	disease	activity	or	physical	function.	
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1.	Introduction	
Literature	review		
Rheumatoid	arthritis	(RA)	is	a	chronic	inflammatory,	autoimmune	disease	of	unknown	
cause	which	affects	synovial	joints	and	results	in	progressive	damage	if	untreated	(Emery,	
2006).	The	estimated	prevalence	of	RA	worldwide	is	1%	(Dowman	et	al.,	2012),	which	is	
similar	to	developing	countries	(Mody	and	Cardiel,	2008).		However	there	is	paucity	of	
epidemiological	data	regarding	the	prevalence	of	RA	in	black	South	Africans	(BSA).	
Females	are	twice	as	affected	than	males,	with	a	peak	incidence	in	the	5th	decade	of	life	
(Alamanos	and	Drosos,	2005).	The	classical	feature	of	RA	is	symmetrical	involvement	of	
the	small	joints	of	the	hands,	namely	the	metacarpal	phalangeal	(MCP)	and	proximal	
interphalangeal	(PIP)	joints	with	sparing	of	the	distal	interphalangeal	joints	(DIP)	(da	Mota	
et	al.,	2012).	
Aside	from	the	health	burden	of	the	disease,	there	is	significant	associated	socio-
economic	impact	related	to	RA	(Rat	and	Boissier,	2004)	as	the	loss	of	physical	function,	
pain	and	swelling	tends	to	typically	involve	the	peripheral	joints	(Dougados	et	al.,	2007).	
1.1.	Diagnosis	of	rheumatoid	arthritis	
The	diagnosis	of	RA	is	made	using	the	2010	ACR-EULAR	classification	(Table	1.1)	(Aletaha	
et	al.,	2010).	The	scores	are	derived	from	4	categories,	namely:	number	and	site	of	
involved	joints	(score	range	0–5),	abnormal	serology	(score	range	0–3),	elevated	acute-
phase	reactants	(score	range	0–1),	and	symptom	duration	(2	levels;	range	0–1).	The	
presence	of	synovitis	in	at	least	a	single	joint	(provided	there	is	no	better	alternate	
diagnosis	accounting	for	the	synovitis)	and	a	total	score	≥	6/10	is	required	to	definitively	
diagnose	RA	(Aletaha	et	al.,	2010).	 
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Table	1.1.	ACR-EULAR	diagnostic	criteria	for	Rheumatoid	Arthritis	
Criteria		 Score†		
A.	Joints		
1	large	joint		 0		
2	-	10	large	joints‡		 1		
1	-	3	small	joints§		 2		
4	-	10	small	joints		 3		
>10	joints		 5		
B.	Serology		
Negative	RF	and	negative	anti-CCP		 0		
Low-positive	RF	or	low-positive	ACPA¶		 2		
High-positive	RF	or	high-positive	ACPA||		 3		
C.	Acute	phase	reactants		
Normal	CRP	and	ESR		 0		
Abnormal	CRP	or	ESR		 1		
D.	Symptom	duration		
<6	weeks		 0		
≥6	weeks		 1		
ACR	=	American	College	of	Rheumatology;		
EULAR	=	European	League	Against	Rheumatism;	RA	=	rheumatoid	arthritis;		
RF	=	rheumatoid	factor;	CCP	=	cyclic	citrullinated	peptide;		
ACPA	=	anti-citrullinated	peptide	antibody;	CRP	=	C-reactive	protein;		
ESR	=	erythrocyte	sedimentation	rate.		
Patients	who	 (i)	have	at	 least	1	 joint	with	definite	synovitis	 (swelling),	 (ii)	with	 the	synovitis	not	
better	explained	by	another	disease.		
†Add	score	of	categories	A	-	D;	a	score	of	≥6/10	is	needed	for	classification	of	a	patient	as	having	
definite	RA.		
‡‘Large	joints’	refers	to	shoulders,	elbows,	hips,	knees,	and	ankles.		
§‘Small	 joints’	 refers	 to	 the	metacarpophalangeal	 joints,	proximal	 interphalangeal	 joints,	 second	
through	fifth	metatarsophalangeal	joints,	thumb	interphalangeal	joints,	and	wrists.		
¶≤3	times	the	upper	limit	of	normal.		
||>3	times	the	upper	limit	of	normal.		
		
Aetiology	of	Rheumatoid	Arthritis		
The	aetiology	is	not	entirely	known	however	it	is	widely	accepted	that	it	occurs	in	a	
genetically	susceptible	host	that	is	exposed	to	an	environmental	trigger	(Alamanos	and	
Drosos,	2005).	Smoking	is	the	only	environmental	trigger	that	has	conclusively	been	
associated	with	the	risk	for	RA.	Smoking	results	in	the	citrullination	of	amino	acids	in	the	
lung	resulting	in	the	production	of	anti-citrullinated	peptide	antibodies	(ACPA)	(Klareskog	
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et	al.,	2011).	Both	ACPA	and	rheumatoid	factor	(RF)	are	the	two	most	commonly	tested	
antibodies	and	predispose	to	more	severe	bony	erosive	RA	(Taylor	et	al.,	2011).		
Disease	activity	and	physical	function	
Disease	activity	is	assessed	using	the	Simplified	Disease	Activity	Index	(SDAI)	(Aletaha	and	
Smolen,	2005)	which	is	a	composite	score	of	the	swollen	joint	count	(SJC),	tender	joint	
count	(TJC),	an	acute	phase	reactant,	c	reactive	protein	(CRP)	as	well	as	patient	and	
physical	global	assessment.	The	clinical	disease	activity	score	(CDAI)	is	the	SDAI	without	
the	CRP.	Physical	disability	is	assessed	using	the	modified	health	assessment	
questionnaire	(mHAQ)	(Pincus	et	al.,	1983).  
1.2.	Imaging	of	rheumatoid	arthritis	
1.2.1.	Role	of	imaging	
In	the	clinical	setting,	imaging	aids	establishing	a	diagnosis	of	RA,	monitoring	joint	
damage,	and	prognosticating	long	term	outcome	(Ostergaard	et	al.,	2008).	X-rays	of	the	
hands	and	feet	guide	treatment	decisions	(van	der	Heijde,	2000).	Interventional	
management	(example	sonar	or	fluoroscopy	guidance)	of	RA	patients	also	relies	on	
imaging	for	joint	aspirations	and	injections	(Balint	et	al.,	2002).	In	the	research	setting,	
imaging	is	useful	to	assess	inflammation,	structural	joint	damage	and	to	evaluate	
effectiveness	of	an	intervention	(Ory,	2003).	
1.2.2.	Plain	film	radiography	hands,	wrists	and	feet	in	RA	
Antero-posterior	projection	plain	films	of	the	hands,	wrists	and	feet	are	used	to	assess	
joint	damage.	A	single	set	of	films	offers	only	a	static	impression	of	the	joints,	however,	
serially	assessed	films	permits	the	physician	to	assess	progressive	joint	damage	(van	der	
Heijde,	2000).	X-ray	features	in	the	hands	and	feet	of	RA	include	juxta-articular	
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osteopenia,	soft	tissue	swelling,	marginal	bone	erosions,	symmetric	joint	space	narrowing	
(which	is	an	indirect	measure	of	cartilage	thickness),	subchondral	cysts,	joint	
subluxations,	dislocation	and	ankyloses.	In	early	RA,	the	joints	most	commonly	involved	
include	MCP,	PIP,	intercarpal	and	distal	radio-ulnar	joints	of	the	hand	and	wrist,	while	
joints	affected	in	the	feet	include	the	metatarsophalangeal	and	PIP’s	(Brown	et	al.,	2008).	
	
	
Figure	1.1.	Antero-posterior	radiograph	of	the	hands	demonstrating	rheumatoid	
arthritis	
Case	courtesy	of	A.Prof	Frank	Gaillard,	Radiopaedia.org,	rID:	2741	
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Advantages	of	X-rays	in	Evaluating	Rheumatoid	arthritis	
The	advantage	of	X-rays,	compared	to	ultrasound	and	MRI,	is	that	they	are	cheap,	readily	
available,	especially	in	low-income	countries	with	limited	resources,	and	can	be	blinded	
for	ease	of	use	in	clinical	trials.	They	also	allow	for	a	permanent	recording	of	joint	damage	
or	severity	(Ory,	2003,	van	der	Heijde,	2000).	It	has	been	shown	by	Lillegraven	that	
damage	in	the	small	joints	are	a	good	surrogate	for	overall	joint	damage	(Lillegraven	et	
al.,	2012).	An	X-ray	of	the	hands	and	wrists	allows	a	significant	amount	of	small	synovial	
joints	to	be	evaluated	using	only	a	single	exposure	(Drossaers-Bakker	et	al.,	2000).	Serial	
radiographs	can	be	used	to	quantify,	and	monitor	the	amount	as	well	as	the	distribution	
of	joint	disease	(Brown	et	al.,	2008).		
Limitations	of	X-rays	in	Evaluating	Rheumatoid	arthritis	
Though	considered	an	imaging	gold	standard	(van	der	Heijde,	2000),	there	are	some	
disadvantages	of	plain	film	radiography,	which	must	be	taken	into	consideration.	A	
limitation	is	that	patient’s	baseline	X-rays	may	only	show	non-specific	osteopenia,	while	
contemporary	treatment	strategy	results	in	RA	patients	being	diagnosed	and	treated	
before	radiographically	evident	erosive	damage	has	developed,	hence	radiographs	may	
underdiagnose	RA	in	the	early	stage	of	disease	(Yazici	et	al.,	2009,	Pincus,	2006).	This	is	
referred	to	as	the	floor	effect	where	pathognomonic	findings	are	only	seen	later	in	the	
course	of	the	disease	(Ory,	2003).	The	ceiling	effect	describes	a	limitation	whereby	
radiographic	and	pathological	damage	continue	despite	the	maximum	score	(according	to	
radiographic	scoring	systems)	being	attained	(Ory,	2003),	resulting	in	an	apparent	plateau	
in	disease	activity	despite	continued	inflammation	and	destruction.	Plain	film	is	not	able	
to	assess	the	disease	progression	affecting	synovium,	cartilage	and	tendons.	Other	
limitations	of	plain	film	radiography	include	limited	sensitivity	for	soft	tissue	structures	
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such	as	the	synovium,	tendons	and	cartilage,	which	play	an	important	role	in	RA	diagnosis	
and	disease	progression	(Tan	and	Conaghan,	2011).		These	structures	are	better	
evaluated	using	ultrasound	and	magnetic	resonance	imaging	(MRI)	(Yazici	et	al.,	2009).	
MRI	and	ultrasound	allow	depiction	of	synovitis,	tenosynovitis,	bursitis,	bone	marrow	
oedema	as	well	as	cortical	erosions	(Boutry	et	al.,	2007,	Ostergaard	et	al.,	2008).		
	
Functional	status	(as	measured	by	the	HAQ)	is	a	better	predictor	of	work	disability,	
premature	mortality	and	costs,	as	compared	to	plain	film	joint	destruction(Pincus,	2006).		
	
1.2.3.	Radiographic	follow	up	and	prognostication	
Studies	have	shown	a	correlation	between	radiographs	and	serological	tests	(CRP,	ESR	
and	RF),	disease	duration	and	joint	deformity,	however	there	is	a	weak	correlation	
between	radiographs	and	patient	pain,	joint	tenderness,	age	and	functional	status	
(Pincus,	2006,	Pincus	and	Sokka,	2003).	In	the	later	stage	of	RA,	there	is	a	significant	
relationship	between	disability	and	joint	damage	(Lillegraven	et	al.,	2012),	which	is	why	
radiographic	damage	has	been	validated	as	an	outcome	measure	for	RA.	An	important	
limitation	is	that	radiographic	findings	are	not	able	to	predict	work	disability,	socio-
economic	costs	nor	mortality.	This	is	better	assessed	using	patient	tools	like	the	HAQ	
(Pincus,	2006).	
1.3.	Radiographic	Scoring	methods	
There	are	two	types	of	scoring	methods:	global	and	detailed.	Global	methods	are	easier	
to	perform	and	involve	assigning	a	single	score	to	each	particular	joint	evaluated,	whereas	
7	
the	detailed	method	allows	for	two	or	more	variables	to	be	quantified	for	each	joint	(Ory,	
2003).	
	
The	modified	Sharp-Van	der	Heijde	(SHS)	method	is	a	detailed	system	that	requires	two	
scores	for	each	joint	-	one	for	joint	space	narrowing	(scored	0	–	4),	the	other	for	erosions	
(scored	0	–	5)	(Table	1.1).	Joint	space	narrowing	is	assessed	in	15	areas	in	the	hands	and	
wrists,	and	6	from	the	feet.	For	the	erosion	component,	16	joints	in	each	hand	and	wrist	
and	12	joints	in	each	foot	are	evaluated	(Boini	and	Guillemin,	2001,	O'Neill,	2015,	Ory,	
2003,	Sokka,	2008).	This	results	in	a	maximum	erosion	score	of	280	and	a	maximum	joint	
space	narrowing	score	of	168,	with	a	total	potential	score	out	of	448.	
	
The	Scott	modification	of	the	Larsen	method	(modified	Larsen’s)	is	a	global	assessment	
tool,	where	joint	space	narrowing	and	erosions	for	each	joint	are	evaluated	together	
against	reference	radiographs.	Joints	assessed	are	the	first	to	fifth	proximal	
interphalangeal	joints,	first	to	fifth	metacarpophalangeal	joints,	the	wrist	(as	a	single	
score,	multiplied	by	5),	and	the	first	to	fifth	metatarsophalangeal	joints,	thus	15	joints	in	
each	hand	and	5	joints	in	each	foot	are	evaluated	for	a	total	score	out	of	200	(Table	1.2)	
(Ory,	2003,	Sokka,	2008,	Boini	and	Guillemin,	2001,	O'Neill,	2015).		
Multiple	studies	have	demonstrated	that	the	scores	from	the	modified	(SHS)	and	Scott-
Larsen	methods	are	significantly	correlated,	even	though	the	former	was	demonstrated	
to	be	more	sensitive	(Boini	and	Guillemin,	2001).	The	modified	Larsen	method	is	less	time	
consuming	and	easier	to	apply	(Ory,	2003,	Finckh	et	al.,	2006,	van	der	Heijde,	2000).			
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Table	1.2.	Sharp	–	Van	der	Heijde	scoring	method	per	joint		
Erosions   Joint space narrowing 
0 – Normal  0 – Normal 
1 – Discreet erosions 1 – Focal narrowing 
2 – 3 – Larger erosions according to surface area 
affected 
2 – Reduction of less than 50% joint space 
4 – Erosion extending over middle of bone 3 - Reduction of greater than 50% joint space 
5 – Complete collapse 4 – Ankylosis 
	
Table	1.3.	Scott	Modified	Larsen	scoring	method	
Score	 Parameter	
0 Intact bony outlines and normal joint space 
1 Erosion less than 1 mm in diameter or joint space narrowing 
2 One or several small erosions, diameter more than 1 mm 
3 One or several small erosions, diameter more than 1 mm, on both sides of the joint 
4 Severe erosions, where there is usually no joint space left, and the original bony outlines 
are partly preserved or subluxation 
5 Mutilating changes, where the original bony outlines have been destroyed 
	
The	(SHS)	and	modified	Larsen	methods	are	used	predominantly	in	research	and	are	
difficult	to	implement	in	a	clinical	setting	(van	der	Heijde,	2000,	Boini	and	Guillemin,	
2001).	A	simplified	scoring	method	was	therefore	developed.	The	Simple	Erosion	
Narrowing	Score	(SENS),	is	based	upon	the	SHS,	and	assesses	the	same	joints	in	the	hand	
and	foot	as	the	SHS	(table	1.3).	16	joints	in	the	hand	and	6	joint	in	the	foot	are	evaluated	
for	erosions	while	joint	space	narrowing	is	considered	in	15	joints	in	the	hand	and	6	joints	
in	the	foot.	The	positive	presence	of	joint	space	narrowing	is	scored	as	1	point,	as	is	the	
presence	of	any	detectable	erosion,	thus	the	maximum	score	per	joint	is	2	(van	der	
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Heijde,	2000).	In	the	hands,	the	maximal	erosion	score	is	32,	and	30	for	
narrowing/subluxation.	In	the	feet,	the	maximal	erosion	score	is	12,	and	12	for	
narrowing/subluxation.	As	a	consequence,	the	range	of	the	SENS	method	is	from	0	to	86	
(van	der	Heijde	et	al.,	1999). 
	
Table	1.4.	SENS	scoring	method	
Erosions	 Joint	space	narrowing	
0	–	absent	 0	-	absent	
1	-	present	 1	-	present	
	
The	SENS	method	affords	similar	disease	progression	rates	as	the	SHS,	however	it	may	be	
limited	by	the	ceiling	effect	later	in	the	course	of	the	disease	by	virtue	of	the	smaller	
score	range.	This	easier	method	has	proven	to	be	reliable	in	early	disease	(van	der	Heijde,	
2000,	Boini	and	Guillemin,	2001).	
	
A	2012	study	by	Barnabe	utilized	the	SENS	and	SHS	methods	to	assess	disease	
progression	and	to	evaluate	if	the	SENS	method	is	reliable	for	clinical	application.	The	SHS	
score	was	performed	by	experienced	clinicians,	and	the	SENS	score	was	derived	from	this	
score.	A	separate	reader	with	no	radiographic	scoring	training	also	performed	the	SENS	
score.	Their	study	found	a	strong	correlation	between	the	SHS	and	both	the	derived	SENS	
as	well	as	the	independently	scored	SENS.	
Although	less	sensitive	than	both	the	modified	Larsen	and	the	SHS,	the	SENS	method	
requires	less	training	and	is	quicker	to	perform	(Barnabe	et	al.,	2012).	
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A	study	by	Solymossy	et	al	in	1999	demonstrated	that	the	Larsen	score	calculated	from	a	
digitized	radiograph	is	comparable	to	the	original	film,	even	with	differing	degrees	of	
erosion	(Solymossy	et	al.,	1999),	thus	validating	Larsen	scores	from	digital	images.	
	
1.4.	Predictors	of	progression	of	rheumatoid	arthritis	
Predictors	of	disease	progression	and	joint	damage	include	positive	RF,	raised	serum	
inflammatory	markers	(ESR	and	CRP),	duration	of	disease	and	joint	swelling,	with	the	
most	rapid	progression	occurring	in	early	disease	(Ory,	2003).	Boers	et	al	found	that	if	a	
particular	joint	demonstrated	damage,	pain	or	swelling	at	diagnosis,	these	factors	were	
predictive	of	progression	of	damage	within	that	joint	(Boers	et	al.,	2001).	This	also	implies	
there	is	a	correlation	between	local	inflammation	and	subsequent	joint	damage.	Another	
predictor	of	functional	decline	is	disease	activity	(Nair	et	al.,	2013).		
	
1.5.	Physical	disability	
The	HAQ	is	a	tool	used	to	measure	disability.	This	tool	is	a	patient	reported	outcome	
which	assesses	twenty	activities	of	daily	living	in	eight	categories:	“dressing	and	
grooming,	arising,	eating,	walking,	hygiene,	reach,	grip	and	common	daily	activities”	
(Pincus	and	Sokka,	2003).	There	are	four	response	options	to	each	activity,	ranging	from	
‘without	any	difficulty’	to	‘unable	to	do’.	According	to	Pincus	et	al,	patient	questionnaires	
are	able	to	predict	functional	loss,	work	disability	and	death	better	than	radiological	and	
laboratory	tests	(Pincus	and	Sokka,	2003)	
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As	the	duration	of	RA	increases,	so	too	does	the	radiographic	joint	damage	and	the	
disability	(Scott	et	al.,	2000).	Scott	et	al	report	that	there	is	a	strong	relationship	between	
X-ray	damage	and	disability,	however	they	explain	that	this	is	only	demonstrated	in	
established	and	late	disease	(Scott	et	al.,	2000).	Lillegraven	and	colleagues	also	found	no	
link	between	the	SHS	and	the	HAQ	in	patients	with	early	RA.	This	finding	is	referred	to	as	
a	‘J-shaped’	curve,	whereby	there	is	an	initial	fall	in	HAQ	scores	after	treatment	initiation,	
with	a	subsequent	increase	over	time	as	the	disease	and	joint	damage	progress	(Scott	et	
al.,	2003).	An	explanation	for	this	is	that	early	disease	patients	have	limited	joint	damage	
but	their	disability	is	attributed	to	pain	and	swelling	from	the	acute	arthritis.		
1.5.1	Non	radiological	factors	affecting	disability	
There	are	multiple	validated	predictors	of	disability	(as	measured	using	the	HAQ	method)	
in	patients	with	RA:	increasing	age,	female	patients,	poor	socio-economic	status	and	
lower	education	level	(Scott	et	al.,	2003,	Scott	et	al.,	2000).	Functional	state	at	
presentation	and	level	of	inflammation	are	also	known	to	be	predictive	of	poor	functional	
outcome	(Emery,	2006).	Disability	in	the	early	phase	of	the	disease	is	more	likely	due	to	
the	active	inflammatory	arthritis	causing	pain	and	swelling(Scott	et	al.,	2000).	
1.5.2	Radiological	factors	affecting	disability	
There	is	a	strong	correlation	between	radiological	joint	damage	and	disability	later	in	the	
course	of	RA.	In	early	RA,	joint	damage	is	not	correlated	to	disability	(Lillegraven	et	al.,	
2012,	Scott	et	al.,	2000).	Later	in	the	disease,	there	is	linearity	between	joint	damage	and	
disability	(Ory,	2003,	Scott	et	al.,	2000,	Lillegraven	et	al.,	2012).		
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1.6.	Disease	activity	
There	is	a	strong	correlation	between	functional	disability	and	disease	activity	throughout	
the	natural	progression	of	RA	(van	der	Heijde,	2001).	It	is	thus	important	to	measure	
disease	activity	to	individualize	and	optimize	patient	treatment.		
	
There	are	predefined	core	sets	of	disease	activity	measures	as	agreed	upon	by	both	the	
European	League	Against	Rheumatism	as	well	as	the	American	College	of	Rheumatology	
(Dougados	et	al.,	2007).	These	variables	include	tender	and	swollen	joint	counts,	global	
assessments	of	disease	activity	as	determined	by	both	the	physician	and	the	patient,	
acute-phase	reactants,	pain	and	assessments	of	physical	disability.	
	
The	Simplified	Disease	Activity	Index	(SDAI)	is	simply	the	sum	of	tender	joint	count,	
swollen	joint	count	(based	on	a	28	joint	assessment),	the	patient	global	assessment	of	
disease	activity	(0-10),	the	physician	global	assessment	of	disease	activity	(1-10)	and	the	C	
reactive	protein	(CRP).	A	total	score	is	calculated	out	of	86,	with	predetermined	values	for	
categorizing	patients	from	remission	to	high	disease	activity	(Smolen,	2003).		
	
The	Clinical	Disease	Activity	Index	(CDAI)	is	a	similar	tool,	however	acute	phase	reactants	
(CRP	or	ESR)	are	excluded	(Dougados	et	al.,	2007)	resulting	in	an	index	that	does	not		
require	blood	testing.	This	means	the	index	can	be	performed	quickly	in	a	clinic	setting.	
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1.7.	Rationale	for	this	study	
It	is	well	established	that	serial	radiological	evaluation	and	radiographic	damage	scoring	in	
patients	with	RA	aids	disease	monitoring	and	response	to	therapy.	There	is	however	
paucity	in	the	South	African	setting	on	Rheumatoid	arthritis	patients	ie:	assessing	
radiographic	damage,	particularly	comparing	different	scoring	methods.	This	study	is	an	
attempt	to	score	radiographic	damage	of	the	hands	and	feet	in	South	African	rheumatoid	
arthritis	patients	using	two	scoring	methods,	Scott	modification	of	the	Larsen	method	and	
the	Simple	Erosion	and	Narrowing	Score	and	to	evaluate	any	correlation	between	these	
scores	and	disability	as	well	as	disease	activity.	These	scoring	methods	have	been	verified	
for	use	clinically	and	in	research	in	early	RA,	however	there	is	no	study	to	date	in	South	
African	RA	patients	assessing	the	correlation	between	these	two	methods,	and	whether	
they	are	interchangeable	in	the	clinical	setting.			
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Study	Objectives	
1.	To	score	radiographic	damage	of	the	hands	and	feet	of	DMARD	naïve	RA	patients	using	
two	scoring	systems	(Scott	modification	of	Larsen’s	score	and	the	Simple	erosion	and	
narrowing	score	(SENS))	
2.	To	test	for	agreement	between	the	two	scoring	methods	
3.	To	correlate	the	two	scoring	methods	with	physical	disability	and	disease	activity	
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2.0	Materials	and	Methods	
2.	1	Study	type	
The	research	paradigm	is	a	cross-sectional	study,	nested	within	the	METEOR	database,	
using	available	radiographs,	laboratory	data	and	available	clinical	information.	
2.	2	Study	population		
The	study	cohort	were	early	RA	patients	attending	the	Arthritis	Clinic	at	the	Chris	Hani	
Baragwanath	Academic	Hospital	(CHBAH),	Johannesburg,	South	Africa.	The	population	
includes	patients	from	the	Measurement	of	Efficacy	of	Treatment	in	the	Era	of	Outcome	
in	Rheumatology	(METEOR)	database	from	01	January	2012	–	31	May	2016.	The	patient’s	
demographic,	smoking	history	and	clinical	and	serological	(ACCP	and	RF)	data	was	
obtained	from	the	online	international	METEOR	database	which	is	used	to	record	patient	
data	at	each	visit	(Koevoets	et	al.,	2010).	The	METEOR	database	was	developed	by	
international	rheumatologists	as	an	online,	free	web-based	program.	Hospitals	and	clinics	
are	able	to	upload	and	maintain	their	patient	databases	within	METEOR	to	allow	access	to	
research	facilities	and	other	international	databases.	Rheumatologists	are	able	to	
document	demographic	data,	disease	activity	and	functional	disability.	Disease	activity	is	
calculated	automatically	according	to	the	preferred	method	(CDAI,	SDAI,	DAS-28	etc.)	
(Koevoets	et	al.,	2010,	van	den	Berg	et	al.,	2014).	Data	can	be	extracted	for	research	from	
METEOR	according	to	the	needs	of	a	particular	study.	
	
Inclusion	criteria	
• Consenting	patients	over	the	age	of	18			
• Fulfilling	the	ACR/EULAR	2010	criteria	for	RA	(Aletaha	et	al.,	2010)	
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• Early	RA	(symptom	duration	≤	2years)		
• DMARD	naïve	at	the	time	radiographs	were	taken	
• Availability	of	baseline	radiographs	of	the	hands	and	feet	on	AGFA	(Mortsel,	
Belgium)	picture	archiving	and	communication	system	(PACS),	which	became	
active	from	1	January	2012	at	CHBAH	
• Availability	of	the	CDAI,	SDAI	and	HAQ		
	
Exclusion	criteria	
• Poor	quality	radiographs	as	determined	by	the	principal	investigator	(PI)	
1. Over	or	under	penetrated	radiographs	
2. Non	inclusion	of	any	joints	in	the	hand	or	foot	
3. Incorrect	radiographic	positioning	that	prevents	accurate	evaluation	of	
joints	
• Factors	affecting	physical	disability	such	as	stroke,	congestive	cardiac	failure,	
neuropathy	and	recent	surgery	
	
2.3.	Methods	
X-ray	Retrieval	Process		
Patients	fulfilling	previously	described	criteria	and	whose	radiographs	were	available	on	
the	Picture	archiving	and	communication	system	(PACS)	were	finally	included	in	the	
study.	This	includes	radiographs	taken	from	1	January	2012	to	30	April	2016.	PACS,	is	a	
computer	application	for	medical	imaging,	which	is	designed	for	radiology	departments.	It	
is	“an	electronic	information	system”	used	for	acquiring,	displaying,	storing	and	
17	
transmitting	radiological	images	(Buabbas	et	al.,	2016).	The	radiographs	were	extracted	to	
a	hard	drive	to	be	reviewed	by	the	PI	(SD)	and	a	second	radiologist	(HM)	independently,	
to	reduce	bias.			
	
X-ray	Reading		
Limited	training	of	both	readers	was	online,	through	a	teaching	website	from	the	
University	of	Sherbrooke,	Canada.	
(http://rheumatology.usherbrooke.ca/?q=scoresharp#section_3).		
Radiographs	of	the	bilateral	hands	and	feet	(antero-posterior	view)	were	read	using	the	
Apple	Mac	JGEG	viewer,	Preview	(version	7),	by	both	radiologists.	Each	set	of	radiographs	
were	initially	read	using	the	modified	Larsen	method,	and	then	the	SENS	scoring	method.	
Radiographic	scores	were	entered	into	a	customized	report	form	using	an	Excel	spread	
sheet	(Appendix	A).	Collated	radiographic	scores	were	evaluated	and	any	variation	of	
≥10%	(9	points	for	Larsen	and	20	points	for	SENS)	between	the	two	readers	were	re-
evaluated	by	both	readers	together,	in	order	to	reach	a	consensus	score.		
Both	readers	were	blinded	to	all	clinical	information	in	each	patient.	
	
Clinical	and	demographic	data	was	extracted	from	METEOR	and	entered	into	a	second	
Excel	worksheet	(Appendix	B)	after	all	the	radiographs	had	been	evaluated.	Thus	the	PI	
who	was	also	a	reader	for	this	study	was	blinded	to	all	clinical	data	during	the	X-ray	
reading	phase.	Radiographic	scores	were	transcribed	from	Appendix	A	to	Appendix	B.		
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Ethics	Approval	
Approval	was	obtained	from	both	the	University	of	the	Witwatersrand	human	research	
ethics	committee	(M160553)	(Appendix	C)	and	the	METEOR	executive	committee	
(M146950)	(Appendix	D).	
Study	numbers	were	used	in	order	to	maintain	confidentiality.	METEOR	automatically	
anonymises	patients’	data	by	provided	a	study	number.	Once	radiographs	were	retrieved	
from	PACS,	they	were	labelled	according	to	study	numbers.	A	key	was	used	to	maintain	
confidentiality.	Only	the	PI	and	supervisors	had	access	to	patients’	numbers	and	study	
numbers	through	the	METEOR	application.	
	
2.4.	Statistical	analysis	
	The	statistical	program	“Statistica”	version	12.7,	as	well	as	STATA	version13.0	was	used	
for	the	analysis.	
The	Student’s	T-test	was	used	to	compare	continuous	variables	and	the	Chi-squared	test	
or	the	two-tailed	Fisher’s	exact	test	if	individual	numbers	were	less	than	or	equal	to	5,	
was	used	for	categorical	variables.	The	correlation	between	the	two	readers’	radiographic	
scores	was	assessed	using	the	Spearman	rank	correlation	test.	This	is	a	non-parametric	
measure	of	rank	correlations	between	two	variables.	The	Spearman’s	covariant	was	also	
used	to	assess	for	correlation	between	the	different	scoring	methods.		
The	modified	Larsen	scores	of	the	two	readers	were	combined	and	the	average	was	
tested	for	correlation	(Spearman	covariant)	between	physical	disability	as	measured	by	
the	HAQ,	and	disease	activity	as	measured	by	the	SDAI	and	CDAI.		The	same	correlation	
was	performed	using	the	SENS	scoring	method.		
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3.	Results	
3.1.	Demographic	data		
Of	the	159	patients	on	the	CHBAH	subset	from	the	METEOR	database	from	1	January	
2012	to	30	April	2016,	95	fulfilled	the	study	inclusion	and	exclusion	criteria.		Majority	of	
the	patients	were	middle	aged	females	(84%)	with	a	mean	disease	duration	of	9.1	months	
and	moderate	disease	activity	(median	CDAI	23.4).	Approximately	a	quarter	(24.2%)	of	
patients	had	smoked	at	some	point	and	majority	(95.5%)	were	seropositive	for	RA.	(Table	
3.1).	
Table	3.1.		Baseline	characteristics	of	included	patients	
	 n=95		
Mean	(SD)	unless	
otherwise	stated	
Female	(%)	 84.8	
Age	in	years		 50.07	(13.8)	
Symptom	duration	(months)	 9.17	(5.6)	
Ever	smoked	(%)	 24.2	
Rheumatoid	factor	(%)	 95.5	
aCDAI											 23.4	(14.1)	
										Swollen	joint	count	(SJC)	(range)	 6.03	(0	–	22)	
										Tender	joint	count	(TJC)	(range)	 7.68	(0	–	27)	
										Patient	global	Visual	analogue	scale	(PG	VAS)	(range)	 6.3	(0	–	10)	
										Physician	global	Visual	analogue	score	(PhG	VAS)	(range)	 5.6	(0	–	10)	
bSDAI	 25.7	(15.2)	
cHAQ	DI	(0-3)	 1.24	(0.8)	
dCRP(mg/l)	 26.8	(34.4)	
20	
eESR(mm/h)	 33.7	(28.3)	
aCDAI	–	Clinical	disease	activity	index;	bSDAI	–	Simple	disease	activity	index	
cHAQ	–	Health	assessment	questionnaire	;	dCRP	–	C-reactive	protein;		
eESR	–	Erythrocyte	sedimentation	rate	
	
	
3.2.	Radiographic	damage	scoring	using	the	modified	Larsens	and	SENS	
scoring	methods	
	Table	3.2.		Baseline	radiographic	scores		
	 n	=	95	
median	(IQR)	
Larsen	reader	1	 		11	(3,	23)	
Larsen	reader	2	 11	(5,	19)	
SENS	reader	1	 7	(3,	11)	
SENS	reader	2	 4	(3,	7.5)	
Larsen	average	(reader	1+2)	 11.25	(3.25,	20.5)	
SENS	average	(reader	1	+	2)	 5.5	(2.75,	9,25))	
All	values	are	median	(SD)	unless	otherwise	stated	
	
The	modified	Larsen	and	SENS	scores	showed	predominantly	early	erosive	change,	with	
most	patients	having	low	scores	(Larsen	scores	<20;	SENS	scores	<10).	The	distribution	of	
scores	was	comparable	between	reader	1	and	reader	2,	as	is	demonstrated	in	figure	3.2.	
There	are	some	patients	who	scored	higher	for	both	SENS	and	the	modified	Larsen,	
demonstrating	more	established	destructive	damage.	
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To	demonstrate	an	example	of	the	scoring	methods,	a	patient’s	X-rays	are	scored	in	
Figure	3.1.	Figure	3.1	is	an	AP	of	the	feet	(Figure	3.1.a)	and	the	hands	(Figure	3.1.b)	of	a	
29	year	old	female	with	RA.	Her	radiographs	demonstrate	erosive	destruction	at	the	left	
1st	and	right	5th	metatarsophalangeal	(MTP)	joint	and	the	1st	interphalageal	(IP)	joints	of	
the	hallux	bilaterally.	In	addition,	there	is	subluxation	of	the	left	5th	MTP.	There	is	an	
incidental	fracture	noted	of	the	left	2nd	metatarsal.	
The	hands	show	erosive	change	involving	both	wrists,	with	the	right	carpus	being	more	
severely	affected.	There	is	loss	of	normal	cortical	margins	as	well	as	indistinct	borders	of	
the	right	distal	carpel	row.	There	is	also	marked	joint	space	narrowing	involving	all	the	
small	joints	about	the	right	wrist.	This	patient’s	average	Larsen	score	was	54	while	her	
average	SENS	score	was	31.	
	
	
	
	
	
	
	
	
	
	
Figure	3.1.a	
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Figure	3.1.b	AP	radiographs	of	the	feet	(	Fig	3.1.a)	and	hands	(Fig	3.1.b)	in	a	29	year	old	
female	RA	patient.		
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Figure	3.2.	Distribution	of	radiographic	scores	for	reader	1	and	2	
	
The	Spearman	rank	correlation	for	Larsen	score	between	reader	1	and	2	(figure	3.3)	was	
significant	(0.914;	p-value	<0.00).	The	data	points	are	clustered	around	the	100%	
correlation	mark	(diagonal	red	line),	with	no	outliers.		
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Figure	3.3.	Scatterplot	of	Larsen	scores	for	reader	1	vs	reader	2	
	
Likewise,	for	SENS	(figure	3.4),	the	Spearman	rank	correlation	between	reader	1	and	2	is	
0.709	(p-value	<0.001).	Despite	the	data	points	being	less	tightly	concentrated	around	the	
100%	correlation	line	than	the	modified	Larsen	scores,	they	are	still	within	close	proximity	
to	it,	and	there	are	no	outliers.	Thus	the	radiographic	scores	between	the	two	readers	
was	better	correlated	for	the	modified	Larsen	than	the	SENS.	
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Figure	3.4.	Scatterplot	of	SENS	scores	for	reader	1	vs	reader	2	
	
When	comparing	the	average	modified	Larsen	to	the	average	SENS	score	(figure	3.5),	
there	is	a	very	strong	correlation	of	0.892	(p-value	0.00).	The	data	points	are	located	
within	close	proximity	to	the	diagonal	line,	which	depicts	perfect	correlation	between	the	
two	methods,	meaning	that	either	of	the	two	methods	can	be	used	interchangeably	in	
early	RA.		
26	
	
Figure	3.5.	Scatterplot	of	Larsen	average	vs	SENS	average	and	correlation	of	methods	
	
3.3.	Radiographic	damage	and	disease	activity	
There	is	direct	correlation	between	modified	Larsen	score	and	inflammatory	markers	ESR	
(0.24;	p-value	0.023)	and	CRP	(0.255;	p-value	0.013)	when	the	Spearman	rank	correlation	
test	is	applied.	Similarly,	SENS	score	is	also	significantly	correlated	with	ESR	(0.312;	p-
value	0.006)	and	CRP	(0.312;	p-value	0.004).		
	
Despite	the	inflammatory	markers	correlating	with	radiographic	damage,	there	is	no	
relation	between	the	modified	Larsen	and	disease	activity	measures:	CDAI	(p-value	0.479)	
and	SDAI	(p-value	0.746)	(Table	3.3).	Similarly,	SENS	score	showed	no	correlation	to	either	
disease	activity	marker	(CDAI	p-value	0.77;	SDAI	p-value	0.86)	(Table	3.5).	The	individual	
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components	making	up	the	SDAI	(TJC,	SJC,	PGA,	PhGA)	also	showed	no	correlation	with	
either	the	modified	Larsen	or	SENS	scores.	(Table	3.3	and	3.4)		
	
There	is	no	significant	correlation	between	disease	duration	and	radiographic	damage	as	
assessed	using	either	SENS	(0.09,	p-value	0.34)	(Table	3.5)	or	the	modified	Larsen	(0.13;	p-
value	0.20)	(Table	3.3).		
	
There	is	no	significant	correlation	between	the	modified	Larsen	score	and	ACCP	(0.00;	p-
value	0.511)	or	RF	seropositivity	(-0.46;	p-value	0.668)	(Table3.3),	despite	the	majority	of	
our	patients	being	seropositive.	Similarly	for	SENS,	there	is	no	significant	correlation	with	
ACCP	(0.00;	p-value	0.670)	and	RF	seropositivity	(-0.40;	p-value	0.551)	(Table	3.4)		
	
Table	3.3.	Square	root	of	the	average	Larsen	score	and	disease	activity		
Variable	 Coefficient	 95%	CI	 P-value	
Disease	duration	 0.04	 -0.022	–	0.109	 0.190	
Smoking		 0.21	 -0.663	–	1.086	 0.633	
aRF	(>14)	 -0.46	 -2.58	–	1.66	 0.668	
bACCP	 0.00	 -0.001	–	0.002	 0.511	
cCDAI	 -0.01	 -0.037	–	0.016	 0.440	
dTJC	 -0.05	 -.0114	–	0.010	 0.102	
eSJC	 -0.06	 -.0137	–	0.021	 0.147	
fPGA	 -0.01	 -0.029	–	0.003	 0.100	
gPhGA	 0.00	 -0.019	–	0.016	 0.888	
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hSDAI	 -0.01	 -0.032	–	0.018	 0.597	
iCRP	 0.0113	 0.010	–	0.022	 0.032	
jESR	 0.01	 -.0004	–	0.024	 0.176	
kHAQ	DI	 -0.35	 -0.805	–	0.115	 0.140	
aRF	–	Rheumatoid	factor;	bACCP	-	Anti-citrullinated	protein	antibodies		
cCDAI	–	Clinical	disease	activity	index;	dTJC	–	Tender	joint	count	
eSJC	–	Swollen	joint	count;	fPGA	–	Patient	global	assessment	
gPhGA	–	Physician	global	assessment;	hSDAI	–	Simple	disease	activity	index	
iCRP	–	C-reactive	protein;	jESR	–	Erythrocyte	sedimentation	rate	
kHAQ	DI	–	Health	assessment	questionnaire	disability	index	
	
Table	3.4.	Square	root	of	the	average	SENS	score	and	disease	activity	
Variable	 Coefficient	 95%	CI	 P-value	
Disease	duration	 0.02	 -0.020	–	0.063	 0.304	
Smoking		 0.20	 -0.349	–	0.748	 0.473	
aRF	(>14)	 -0.40	 -1.728	–	0.928	 0.551	
bACCP	 0.00	 -0.001	–	0.001	 0.670	
cCDAI	 0.00	 -0.019	–	0.015	 0.810	
dTJC	 -0.02	 -0.062	–	0.017	 0.261	
eSJC	 -0.02	 -0.068	–	0.032	 0.479	
fPGA	 0.00	 -0.008	–	0.014	 0.627	
gPhGA	 -0.01	 -0.017	–	0.002	 0.134	
hSDAI	 0.00	 -0.016	–	0.015	 0.978	
iCRP	 0.008	 0.002	–	0.149	 0.007	
jESR	 0.01	 -0.001	–	0.016	 0.071	
kHAQ	DI	 -0.87	 -2.595	–	0.860	 0.321	
aRF	–	Rheumatoid	factor;	bACCP	-	Anti-citrullinated	protein	antibodies		
cCDAI	–	Clinical	disease	activity	index;	dTJC	–	Tender	joint	count	
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eSJC	–	Swollen	joint	count;	fPGA	–	Patient	global	assessment	
gPhGA	–	Physician	global	assessment;	hSDAI	–	Simple	disease	activity	index	
iCRP	–	C-reactive	protein;	jESR	–	Erythrocyte	sedimentation	rate	
kHAQ	DI	–	Health	assessment	questionnaire	disability	index	
	
There	is	no	significant	correlation	between	the	average	modified	Larsen	score	and	the	
HAQ	score	(r	=	-0.168;	p-value	0.105)	as	well	as	between	the	average	SENS	and	HAQ	(r=	-
0.101;	p-value	0.333)	using	the	Spearman’s	covariant	(Table	3.5)	
	
Table	3.5.	Spearman	rank	correlation	between	radiographic	damage	scores	and	HAQ	
	 Spearman	R	 P	-	value	
Average	Larsen	score	&	HAQ	 -0.168	 0.105	
Average	SENS	score	&	HAQ	 -0.101	 0.333	
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4.	Discussion	
4.1.	Results	in	context	
A	radiographic	score	is	a	quick,	cheap	and	easily	accessible	means	of	assessing	joint	
damage	in	RA	patients.	Adopting	a	simple	and	sensitive	scoring	method	may	be	beneficial	
to	the	clinician.	This	study	demonstrates	a	strong	correlation	between	the	Scott	
modification	of	the	Larsen	scoring	system	and	the	SENS	score,	when	assessing	
radiographic	damage	in	early	RA	on	X-rays	of	the	hands	and	feet.	Our	results	in	a	South	
African	context	are	similar	to	the	study	by	Guillemin	et	al	(Norway,	France),	who	
compared	five	different	scoring	methods	(Guillemin	et	al.,	2005).	In	addition	the	scoring	
methods,	including	Larsen	and	SENS,	had	good	inter-	and	intraobserver	reliability.	Lastly,	
as	disease	severity	increased,	the	interobserver	reproducibility	worsened.		
	
Multiple	studies	showed	that	the	SENS	method	is	more	sensitive	in	early	disease	(Boini	
and	Guillemin,	2001,	van	der	Heijde,	2000).	A	recent	study	(Barnabe	et	al.,	2012)	found	
the	SENS	performed	well	in	cross	sectional	studies,	with	good	interobserver	reliability,	
however	it	was	noted	to	be	significantly	less	sensitive	to	change	in	joint	destruction	over	
time.	Thus	the	SENS	was	recommended	for	use	in	clinical	practice	or	observational	
studies.	The	poor	sensitivity	of	SENS	with	progressive	disease	is	attributed	to	the	narrow	
range	of	scores,	resulting	in	the	ceiling	effect,	therefore	for	monitoring	disease	
progression	or	radiographic	damage	in	established	disease,	an	alternate	radiographic	
scoring	systems	(such	as	the	Sharp,	Sharp/van	der	Heijde	or	the	Larsen	modification)	is	
recommended.		
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The	interobserver	reliability	of	the	Scott	modification	of	the	Larsen	system	demonstrated	
in	this	study	(r	=	0.892)	is	similar	to	a	previous	study	in	2001	(r	=	0.92)	(Boini	and	
Guillemin,	2001).	These	results	are	promising	considering	that	there	was	no	formal	
training	of	the	radiologists	in	either	of	the	radiographic	scoring	systems	by	an	experienced	
rheumatologist	nor	musculoskeletal	radiologist	prior	to	the	study.	There	was	limited	
online,	web-based	training	for	both	readers	through	the	University	of	Sherbrooke,	
Canada.	(http://rheumatology.usherbrooke.ca/?q=scoresharp#section_3).	Guillemin	et	al	
recommend	that	trained	readers	be	used,	as	they	perform	more	accurately	in	the	method	
for	which	they	were	trained.	However,	in	a	study	conducted	in	the	Netherlands,	there	
was	no	significant	interobserver	variability	difference	between	the	scores	of	trained	and	
untrained	readers	(Zijlstra	et	al.,	2002)	
	
The	time	to	score	seven	sets	of	hand	and	feet	radiographs	is	3.9	minutes	for	the	Larsen	
method	and	7	minutes	for	the	SENS	method	(van	der	Heijde	et	al.,	1999,	Wassenberg	S,	
1998).	Given	that	there	is	good	correlation	between	the	SENS	score	and	the	Larsen	score	
in	early	RA,	it	is	recommended	to	utilize	the	Larsen	method	in	a	busy	clinical	setting.	
	
In	this	study,	there	was	no	correlation	between	radiographic	damage	and	functional	
disability.	These	results	are	similar	with	a	study	performed	in	2005	(Plant	et	al.,	2005)	that	
assessed	the	HAQ	score	in	relation	to	the	modified	Larsen	score	(r	=	-0.06).	They	found	
that	in	early	disease,	disability	was	more	strongly	correlated	with	CRP	(r=	0,24)	and	other	
markers	of	active	inflammation.	This	study	goes	on	to	show	a	significant	correlation	at	5-
year	follow	up	between	radiographic	damage	and	HAQ	score.	As	previously	shown	the	
correlation	between	joint	damage	and	functional	disability	increases	with	disease	
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duration	while	functional	disability	and	radiographically	evident	damage	are	often	not	
correlated	early	in	RA	(Scott	et	al.,	2000,	Scott	et	al.,	2003).	
	
Table	4.1.	Summary	of	studies	that	estimate	correlation	between	functional	disability	
and	radiographic	joint	damage	at	baseline	
Study	 Variable	 Statistical	test		 Correlation	(p	
value)	
Eberhardt	(1995)	 aHAQ	vs	modified	
Larsen	
Spearman’s	correlation	 0.008	(>0.05)	
Fex	(1996)	 HAQ	vs	Larsen	 Spearman’s	correlation	 0.11	(>0.005)	
Mottonen	(1998)	 HAQ	vs	Larsen	 Spearman’s	correlation	 -0.03	(>0.05)	
Gordon	(2001)	 HAQ	vs	Larsen	 Spearman’s	correlation	 0.465	(0.001)	
Plant	(2005)	 HAQ	vs	modified	Larsen	 Spearman’s	correlation	 -0.06	(>0.05)	
Daya	2016	 HAQ	vs	modified	Larsen	
HAQ	vs	SENS	
Spearman’s	correlation	 -0.168	(>0.05)	
-0.101	(>0.05)	
aHAQ	–	Health	assessment	questionnaire;	
Table	4.1.	adapted	from	Bombardier	et	al	(Bombardier	et	al.,	2012)	
	
Scott	et	al	(Scott	et	al.,	2003)	explain	that	there	is	either	a	weak	or	no	correlation	
between	radiographic	damage	and	disability	in	early	RA.	This	is	explained	by	the	J-shaped	
curve	of	disease	duration	and	functional	disability.	High	levels	of	disability	in	early	disease	
tend	to	improve	on	treatment	and	when	inflammation	is	decreased.	As	disease	
progresses,	the	HAQ	increases	as	irreversible	joint	damage	results	in	permanent	disability	
(Bombardier	et	al.,	2012).	Multiple	previous	studies	showed	that	radiographic	damage	
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exerts	a	significant	effect	on	functional	disability	but	only	after	6	to	12	years	(Scott	et	al.,	
2000)	(Welsing	et	al.,	2001)	(Ory,	2003).	Another	explanation	for	the	disconcordance	
between	the	HAQ	score	and	radiographic	damage	may	be	that	HAQ	may	cause	large	joint	
dysfunction,	while	both	the	Larsen	and	SENS	scores	evaluate	only	small	joints.	In	this	
study,	only	small	joints	were	evaluated.	
	
Disease	activity	has	long	been	known	to	be	an	important	outcome	and	therapeutic	target	
in	RA	trials	as	well	as	in	clinical	practice.	This	is	because	it	plays	a	central	role	in	the	
relationship	between	disease	activity,	joint	damage	and	functional	impairment	(Aletaha	
and	Smolen,	2009)	by	virtue	of	the	fact	that	it	causes	joint	damage	which	eventually	
results	in	loss	of	function.	This	study	was	cross-sectional	at	the	time	of	diagnosis,	prior	to	
any	therapy	being	instituted.	The	correlation	between	disease	activity	(as	measured	by	
CDAI	and	SDAI)	and	radiographic	damage	was	not	significant,	however	there	was	a	
significant	correlation	between	acute	phase	reactants	(CRP	and	ESR)	with	radiographic	
scores.	Previous	studies	have	demonstrated	that	there	is	a	positive	correlation	(r=	0.59	
for	CDAI,	p-value	<0.0001)	(Anderson	et	al.,	2011),	(CDAI	r=0.59	and	SDAI	r=0.54)	(Aletaha	
et	al.,	2005)	however	these	studies	were	longitudinal,	assessing	the	relationship	between	
change	in	disease	activity	relative	to	change	in	radiographic	score,	thus	using	time	
averaged	values.	It	has	been	previously	demonstrated	that	the	radiographic	progression	
in	patients	with	early	RA	is	not	linear,	and	that	fluctuation	in	disease	activity	were	
associated	with	joint	damage,	but	that	this	is	a	longitudinal	relationship	(Welsing	et	al.,	
2004).	This	highlights	the	need	to	monitor	disease	activity	closely	in	patients	with	RA	to	
guide	therapy	options,	with	the	end	goal	of	achieving	remission.	
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Earlier	studies	found	that	radiographic	damage	is	a	result	of	the	additive	effects	of	the	
disease	prior	to	the	current	measure	of	disease	activity.	This	study	(van	Leeuwen	et	al.,	
1997)	showed	that	inflammatory	markers	CRP	and	ESR	are	closely	correlated	with	
radiographic	damage.	Subsequent	work	(Aletaha	et	al.,	2005)	has	shown	that	acute	phase	
reactants	are	not	significantly	contributory	to	disease	activity	scores.	
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4.2.	Limitations	of	the	current	study	
A	limitation	of	our	study	is	that	neither	of	the	readers	are	experienced	nor	formally	
trained	musculoskeletal	radiologists.	There	was	also	no	formal	training	of	the	readers	by	a	
musculoskeletal	radiologist.	The	limited	training	was	online,	through	a	teaching	website	
from	the	University	of	Sherbrooke,	Canada	
(http://rheumatology.usherbrooke.ca/?q=scoresharp#section_3).			
	
There	was	an	agreed	acceptable	variance	(<10%)	between	the	readers	for	each	patients’	
Larsen	and	SENS	scores,	as	a	result,	second	read	consensus	agreements	for	32	(33,7%)	
patients	was	performed.	The	importance	of	a	limited	variance	is	that	the	statistical	
analysis	between	radiographic	scores	and	secondary	variables	assessed	in	the	study	(HAQ,	
CDAI,	SDAI,	CRP	&	ESR)	is	more	reliable	and	not	swayed	by	incorrect	radiographic	scores.	
The	limitation	of	this	decision	is	that	the	agreement	between	scores	of	reader	1	and	2	are	
skewed.	
The	cross	sectional	nature	of	this	study	also	limits	the	conclusions	that	one	can	
extrapolate	between	radiographic	damage,	disease	activity	and	functional	disability.	
Future	prospective	studies,	also	evaluating	patients	on	treatment	for	RA	can	follow	this	
South	African	cohort	of	patients	to	see	if	the	relationship	between	radiographic	damage	is	
similar	to	study	populations	globally.	
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4.3.	Future	applications		
The	current	study	utilised	two	radiologists	to	score	the	radiographs.	A	potential	future	
application	would	be	to	perform	a	similar	study	using	a	rheumatologist	and	a	radiologist.	
The	rheumatologist	would	benefit	in	every	day	practice,	by	using	radiographic	scores	to	
have	an	immediate	idea	of	patients’	disease	progression,	thus	guiding	treatment.	The	
rheumatologist	also	has	a	good	understanding	of	each	particular	patient’s	background	as	
well	as	clinical	examination	findings.	This	may	result	in	him	focusing	on	particular	joints	
when	assessing	radiographs.	Radiographic	damage	scoring	can	be	performed	by	either	
the	rheumatologists	or	the	radiologists.	The	marked	staff	shortage	at	CHBAH	means	that	
plain	film	radiographs	of	patients	attending	the	arthritis	clinics	are	not	reported,	let	alone	
scored	for	radiographic	damage.	These	X-rays	are	interpreted	by	the	attending	physician	
or	rheumatologist	in	the	clinics.	Ideally,	collaboration	between	the	radiology	and	
rheumatology	department	should	be	set	up	to	facilitate	training	for	radiographic	scoring	
for	both	specialities.	The	benefits	of	this	would	be	twofold:	patient	management	would	
be	improved	and	teaching	of	trainee	rheumatology	and	radiology	doctors	to	enhance	
their	skills.		
	
4.4.	Conclusion	
This	aim	of	this	study	was	to	score	radiographic	damage	in	early	rheumatoid	arthritis	
using	two	scoring	systems.	We	have	demonstrated	that	there	is	strong	agreement	
between	the	Larsen	and	SENS	methods,	and	that	these	systems	are	useful	in	early	RA	
disease.	The	relatively	simple	nature	of	performing	these	scores	means	that	they	can	be	
performed	in	everyday	clinical	practice	with	minimal	formal	training,	as	a	means	to	gauge	
disease	severity	and	to	guide	future	management.		
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There	is	no	significant	correlation	between	the	radiographic	scores	and	disease	activity	
scores,	however	the	inflammatory	markers	(which	make	up	a	part	of	the	disease	activity	
scores)	are	statistically	correlated	to	both	the	SENS	and	modified	Larsen	scores.		
	
There	is	no	correlation	between	functional	disability	and	radiographic	damage	scores	of	
patients	with	early	RA.	Continued	longitudinal	radiographic	monitoring	is	of	more	value	
than	a	single	evaluation	of	joint	damage	at	initial	presentation	to	the	health	care	
provider.			
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